Search results

Home News Articles {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"

Home News...

With around 2 million healthtech products registered for UK use, differentiating your innovation from the competition is vital. A NICE recommendation helps you cut through the noise, demonstrate your product’s value and smooth your path to market.

Home What NICE does Our guidance About HealthTech guidance NICE: backing the healthtech that changes lives {"@context":"http://schema.org","@ty

Following the government’s 10 Year Health Plan for England, we're strengthening our role in getting the best healthtech, including digital tools, diagnostics and medical devices, to patients.

View a complete list of all our guidance, NICE advice and quality standards currently in development

Find out what guidance is being considered for development

Evidence-based recommendations on selective internal radiation therapy (SIRT) for primary hepatocellular carcinoma. This involves infusion of microspheres loaded with yttrium-90, which aims to deliver radiation directly into the tumour, minimising the risk of radiation damage to healthy surrounding tissues.

Result type

HealthTech guidance

Published

23 July 2013

Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.

Result type

HealthTech guidance

Published

27 January 2022

Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.

Result type

HealthTech guidance

Published

8 March 2021

Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury.

Result type

HealthTech guidance

Published

12 November 2014

Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta.

Result type

HealthTech guidance

Last updated

1 October 2018

Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease.

Result type

HealthTech guidance

Last updated

25 January 2024

Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1-2-3, DELFIA Xpress sFlt-1/PLGF 1-2-3 ratio, Elecsys immunoassay sFlt-1/PLGF ratio, Triage PLGF Test.

Result type

HealthTech guidance

Published

27 July 2022

Evidence-based recommendations on epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer. This involves radioactive paste being spread on foil over the top of the cancer, to destroy the cancer cells.

Result type

HealthTech guidance

Published

2 April 2024